Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Paxmedica Inc (NQ: PXMD ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Paxmedica Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering November 20, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Monday's Intraday Session November 20, 2023 Via Benzinga Crude Oil Gains Over 2%; PaxMedica Shares Plunge November 20, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why PaxMedica Stock (PXMD) Is Down Nearly 40% Today November 20, 2023 PaxMedica, Inc. (NASDAQ: PXMD) shares are trading lower by 38% to $1.09 Monday morning. The company on Monday disclosed the pricing details for its public offering. Via Benzinga US Stocks Rise; Nasdaq Gains Over 50 Points November 20, 2023 U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 50 points on Monday. Following the market opening Monday, the Dow traded up 0.12% to 34,988.28 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities What's Going On With PaxMedica Stock Today? November 14, 2023 PaxMedica, Inc. (NASDAQ: PXMD) shares are trading higher on Tuesday. The stock has been volatile over the past month. Via Benzinga PaxMedica Announces Pricing of $7.0 Million Public Offering November 20, 2023 Via ACCESSWIRE Study Examines Role of African Sleeping Sickness in Body Wasting November 17, 2023 Via Investor Brand Network BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Syndicated Audio Broadcast November 17, 2023 Via Investor Brand Network Exposures Product Safety Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket November 17, 2023 Shares of The Gap, Inc. (NYSE: GPS) jumped in pre-market trading after the company reported better-than-expected financial results for the third quarter on Thursday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday November 17, 2023 It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Intraday Session November 16, 2023 Via Benzinga BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Releases Q3 2023 Financial Report, Corporate Update November 16, 2023 Via Investor Brand Network Exposures Product Safety PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update November 15, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's After-Market Session November 14, 2023 Via Benzinga Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 14, 2023 Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Via Benzinga PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates November 14, 2023 Via Investor Brand Network Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket November 14, 2023 INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday November 14, 2023 We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning! Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session November 13, 2023 Via Benzinga BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release November 09, 2023 Via Investor Brand Network Exposures Product Safety 12 Health Care Stocks Moving In Wednesday's Intraday Session November 08, 2023 Via Benzinga What's Going On With PaxMedica (PXMD) Stock Today? November 08, 2023 PaxMedica Inc (NASDAQ: PXMD) shares are trading lower by 11% to $4.00 Wednesday morning, pulling back following Tuesday's strength. The company on Tuesday announced research findings in the Annals of... Via Benzinga Study Finds Autism Compromises Sleep Quality, Physical Activity in Kids November 07, 2023 Via Investor Brand Network Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 07, 2023 Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. Via Benzinga BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Phase 2 Study Results Published in Peer-Reviewed Journal November 07, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Tuesday's Intraday Session November 07, 2023 Via Benzinga Why Is TransMedics (TMDX) Stock Up 53% Today? November 07, 2023 TransMedics stock is taking off on Tuesday as TMDX investors react to strong revenue and a guidance increase in its Q3 earnings report. Via InvestorPlace Why Is PaxMedica (PXMD) Stock Up 95% Today? November 07, 2023 PaxMedica stock is taking off with heavy trading of PXMD shares following positive results from a Phase 2 clinical trial. Via InvestorPlace Why PaxMedica (PXMD) Stock Is Up Over 100% Today November 07, 2023 PaxMedica Inc (NASDAQ: PXMD) shares are trading higher by 175% to $8.39 Tuesday morning after the company announced research findings in the Annals of General Psychiatry regarding a study on low-dose... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.